{"id":"https://genegraph.clinicalgenome.org/r/36b554f2-0f80-454c-b595-cd771f31d7bbv1.1","type":"EvidenceStrengthAssertion","dc:description":".","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/36b554f2-0f80-454c-b595-cd771f31d7bb","GCISnapshot":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:classificationChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10061","date":"2021-10-13T20:24:53.810Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10061","date":"2021-06-15T18:59:19.142Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14e0d6f2-3ef5-4f50-bc5f-7e5f2bae1707","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2f7d1a0-8578-4686-93f6-86c7f14a6275","type":"Finding","dc:description":"CAPN3 not detected or decreased in LGMD2A (eg. lane 2 hom splice mutaiton, lane 4 compound het LOF/ms).\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9777948","rdfs:label":"CAPN3 expression in control samples, LGMD2A, and other MD. ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9e342e2e-395c-425e-b674-21e27c370ad7","type":"EvidenceLine","dc:description":"Scored with PMID: 9777948 expression A. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28c15dd0-de5c-44b7-bffb-893d3648eff4","type":"Finding","dc:description":"In situ hybridization detection of CAPN3 mRNA in skeletal muscle at 8-week gestation onward. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9521867","rdfs:label":"In situ detection of CAPN3 mRNA in skeletal muscle","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/622b8aa2-8aee-455b-a015-5397718250e1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3db506ff-d1b2-40b1-8723-790f082228fd","type":"Finding","dc:description":"CAPN3 94 kD and 60 kD fragements were detected by DYSF antibody pulldown from human muscle homogenates, but not by an unrelated antibody. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15827562","rdfs:label":"Co-immunoprecipitation of CAPN3 by dysferlin antibody","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/857b8b98-ccfe-4a8b-a485-e3c11aa77dda","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/039e267e-ad43-4bbf-9625-ef2c9af47f0b","type":"Finding","dc:description":"CAPN3 detection by multiple antibody in fresh human muscle tissue and breakdown post homogenization\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9777948","rdfs:label":"Detection of CAPN3 by multiple antibody in skeletal muscles.","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/41a60fca-517e-489e-8afb-caeb1849e09b","type":"EvidenceLine","dc:description":"Reserved as variant evidence for V98I, I161L, ?R448H, D705G, C129S.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b777dbf-d8a8-4147-8e3b-e4967af12a5b","type":"Finding","dc:description":"Major sarcomere protein TTN is one substrate of CAPN3, shown by solid-phase binding assay. Expression V98I, I161L, R448H, D705G mutants showed with reduced TITIN binding, while C129S showed similar binding as wild type protein.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15138196","rdfs:label":"CAPN3 and mutant interaction with TTN","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b060f42d-ef8f-4a2d-b1c2-126179aca265","type":"EvidenceLine","dc:description":"Scored expression B in PMID: 9777948. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7d9fe03-5511-46bc-939d-9460d68ec674","type":"Finding","dc:description":"In healthy control, phase contrast immunofluorescence detected CAPN3 in dystrophin bordered myofibers and presumably satellite cells. CAPN3 staining was not detected in multiple LGMD2A patient biopsies. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10229226","rdfs:label":"Immunostaining did not detect CAPN3 in LGMD2A patients. ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c8415ae5-b5e6-4761-8b63-74e14118802e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ffe7e21-297a-4706-ae62-7e0a4c8691b8","type":"Finding","dc:description":"TTN is a confirmed CAPN3 substrate interaction shown by solid-phase binding assay.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15138196","rdfs:label":"TTN interaction with CAPN3 protein","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/354a108b-a469-4770-956d-16296381c13e","type":"EvidenceLine","dc:description":"AHNAK is present in DYSF complex and may be involved in regeneration. Score 0 as not proven essential for muscle function. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a2f410bf-956a-4419-a732-b1af291cba96","type":"Finding","dc:description":"AHNAK interacts with CAPN3 shown by GST pull-down assay and can be cleaved by CAPN3. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18334579","rdfs:label":"AHNAK CAPN3 GST pull-down","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05eadca4-1e1f-412d-92fa-c45ac01024cc","type":"EvidenceLine","dc:description":"Tracking if tg as AD animal model. ","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4fba1694-a939-43c5-93a4-0421cdaa6f6e","type":"FunctionalAlteration","dc:description":"Loss of CAPN3 D705G mutant protein expression and decreased wild type CAPN3 protein in skeletal muscle.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21624972","rdfs:label":"CAPN3 D705G transgene"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/41adaacd-ff78-4365-9793-7f22b2342453","type":"EvidenceLine","dc:description":"Tracking if tg as AD animal model. ","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f76998c-cb95-4c24-991e-8f475312bcdd","type":"FunctionalAlteration","dc:description":"CAPN3 R448H mutant is showed as less stable in transgenic muscle, which could be attributed to cellular protease mediated degradation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21624972","rdfs:label":"CAPN3 R448H tg"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1c3f0755-578c-4e14-ac8d-0e0ff0aa8536","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20243f6f-bea3-434b-84eb-97d4626d81c8","type":"FunctionalAlteration","dc:description":"Elevation of IKBA staining in LGMD2A muscle and correlation with elevated apoptosis; transient IKBA overexpression induced apoptosis in control muscle cells. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10229226","rdfs:label":"LGMD2A muscle biopsy with elevated apoptosis and IKBA misreg"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed42b1c9-228f-4cfb-a666-cb91acc3d8dc","type":"EvidenceLine","dc:description":"Lower the points due to double knockout background, keep tracking.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/374db109-06ea-4b7f-9906-1a28bdc9750e","type":"Finding","dc:description":"Improvement based on marker gene expression on regeneration, macrophase infiltration, and fibrosis. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31776291","rdfs:label":"AAV delivered CAPN3 expression in CAPN/DYSF double knockout","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/14849629-3286-4a17-94b9-3df7ace38cb8","type":"EvidenceLine","dc:description":"Higher points: comprehensive assessment on expression level, isoform, and clear improvement based on histology for the major phenotype. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/571a6058-0d24-4070-885d-2153cb91aa16","type":"Finding","dc:description":"Histological analysis of muscle biopsy showed evident improvement on muscle dystrophic defects by AAV medicated CAPN3 expression.  AAV medicated CAPN3 expression had positive effects on muscle mess and force with some variations in muscle and injection site. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16290124","rdfs:label":"AAV1-C512-CAPN3fsr expression in CAPN3 -/- muscle","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0aeb9f7d-b5c1-4da2-98d3-09a60789bd38","type":"EvidenceLine","dc:description":"lower with one feature here and main focus is potential cardiotoxicity? \n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ad043c6-caa6-43cd-a4ab-1445982272f6","type":"Finding","dc:description":"AAV derived expression of CAPN3 (confirmed by mRNA and protein analysis) reduced the presence of centronucleated fiber in CAPN3 knockout mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23908349","rdfs:label":"CAPN3 expression correct muscle pathology in murine model.","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ccec45c9-1e51-41a3-8ab7-af2068110cb7","type":"EvidenceLine","dc:description":"Change for AD or AR?","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dce89cbf-460d-409c-b89c-9ad9f1ea9677","type":"Finding","dc:description":"Muscle biopsies of CAPN3 gene knockout mice demonstrated similar pathological changes observed in LGMD patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15138196","rdfs:label":"CAPN3 mouse knockout by gene trap","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1ebdc11b-5414-4dde-92b8-41805181330e","type":"EvidenceLine","dc:description":"AD, AR, Residueal protein. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51137971-fb8b-4b9c-89fb-25a3d86504c2","type":"Finding","dc:description":"High Ck, muscle dystrophic change, loss of sarcolemal integrity, central nuclei, and elevated apoptosis are all features observed in LGMD2A patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11134085","rdfs:label":"Targeted CAPN3 ex2-3","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c017a7ee-3968-4aae-be93-57fd36b975ad_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Score at 0 due to lack of confirmed pedigree and segregation; however LOF and missense with functional evidence.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66a46704-48d3-4093-b5da-0646968e8896","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10330340","rdfs:label":"Greece-University of Newcastle","detectionMethod":"Multiple and nonuniform strategies were applied in this study.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"symmetrical and selective atrophy of the pelvic, scapular, and trunk muscles","phenotypes":["obo:HP_0003236","obo:HP_0008946","obo:HP_0009060"],"secondTestingMethod":"Genotyping","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c017a7ee-3968-4aae-be93-57fd36b975ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10330340","allele":[{"id":"https://genegraph.clinicalgenome.org/r/9747977e-8512-4d74-b481-bacff0e48ffe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.2114A>G (p.Asp705Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA392001588"}},{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.550del (p.Thr184ArgfsTer36)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA220352"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/aadb5260-56e5-4c98-9e73-c4ad09dea12a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Consider high-frequency mutation, keep default score. PMID-14578192, compound heterozygous with missense variant with lowered protein expression Fig.3. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2024c1d3-b977-47db-86b0-5942dece3041","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"III-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":10,"phenotypeFreeText":"Limb girdle wastinng, Scapulohumeral distribution at the beginning, extensor digitorum brevis muscle hypertrophy","phenotypes":"obo:HP_0003236","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/aadb5260-56e5-4c98-9e73-c4ad09dea12a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/4c0f65af-c31c-461d-9f9c-07ebb32155e2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Scored by one LOF;  Interesting to track the del21 mutation.\n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49ef0c09-32b9-4462-8c83-b88e8c829a4a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"II-1","phenotypeFreeText":"CK at 5000","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4c0f65af-c31c-461d-9f9c-07ebb32155e2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":[{"id":"https://genegraph.clinicalgenome.org/r/1d2a26e0-50ce-4c58-a9a0-11a24312635d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.2362_2363delinsTCATCT (p.Arg788SerfsTer14)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127307"}},{"id":"https://genegraph.clinicalgenome.org/r/95c8d89e-dcac-47dc-960f-89d5c1f9f59c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.643_663del (p.Ser215_Gly221del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347563"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:BiallelicCompoundHeterozygous"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/05126a7a-1fb9-48fb-b2a6-4bd982a36a44_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Homozygous LOF. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c72e7f54-370b-4ea9-9248-e1934db681a2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"1135","firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/05126a7a-1fb9-48fb-b2a6-4bd982a36a44_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e24035d-4e29-4de9-acbf-ef08dc597654","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.328C>T (p.Arg110Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341471"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1222926f-9494-450e-8ac5-cda26eddb668_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32896923","rdfs:label":"F2","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/1222926f-9494-450e-8ac5-cda26eddb668","type":"Family","rdfs:label":"F2","member":{"id":"https://genegraph.clinicalgenome.org/r/835bd478-7f96-4748-8758-ccb3b1458480","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32896923","rdfs:label":"II:2","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003236","obo:HP_0003327","obo:HP_0008994"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4a9678fb-e1b1-42e9-8523-548cafbefc37_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32896923","allele":{"id":"https://genegraph.clinicalgenome.org/r/45b38189-d95f-49ba-a430-94281e7d715a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.1706T>C (p.Phe569Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10606813"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0003236","obo:HP_0003327","obo:HP_0008994","obo:HP_0003326"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/835bd478-7f96-4748-8758-ccb3b1458480"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e7700425-ada1-44b7-9ba6-7533955b500b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"A","family":{"id":"https://genegraph.clinicalgenome.org/r/e7700425-ada1-44b7-9ba6-7533955b500b","type":"Family","rdfs:label":"A","member":{"id":"https://genegraph.clinicalgenome.org/r/26357d11-b566-4224-9fbf-305860bc3b85","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"Amish","firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/489a4a05-75df-4008-a527-c012ee19d437_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf2f5322-0416-49fc-bf50-abce83b272b7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.2306G>A (p.Arg769Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127306"}},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Autosomal recessive"},"phenotypeFreeText":"General LGMD, high penetrance,","phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/26357d11-b566-4224-9fbf-305860bc3b85"}},{"id":"https://genegraph.clinicalgenome.org/r/459cd41d-6964-4220-9347-2a9edf52aac6_proband_segregation","type":"FamilyCosegregation","dc:description":"Four generation pedigree, however complete genotyping data are unavailable.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28881388","rdfs:label":"Family 1","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/459cd41d-6964-4220-9347-2a9edf52aac6","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/059d1dfe-4ecb-432f-bf13-aee6e471023a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28881388","rdfs:label":"IV-16","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":65,"detectionMethod":"NGS panels and single gene test on the proband. ","firstTestingMethod":"Next generation sequencing panels","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5e6f415c-19fb-4d44-87b2-62c92a803bf2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28881388","allele":{"id":"https://genegraph.clinicalgenome.org/r/95c8d89e-dcac-47dc-960f-89d5c1f9f59c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0003701","obo:HP_0003236"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/059d1dfe-4ecb-432f-bf13-aee6e471023a"}},{"id":"https://genegraph.clinicalgenome.org/r/54ce1a42-fbce-488a-ae4c-76236028ffc7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"B519","estimatedLodScore":7.17,"family":{"id":"https://genegraph.clinicalgenome.org/r/54ce1a42-fbce-488a-ae4c-76236028ffc7","type":"Family","rdfs:label":"B519","member":{"id":"https://genegraph.clinicalgenome.org/r/c72e7f54-370b-4ea9-9248-e1934db681a2"},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":true,"phenotypeFreeText":"General LGMD, high penetrance,","phenotypeNegativeAlleleNegative":14,"phenotypePositiveAllelePositive":10,"proband":{"id":"https://genegraph.clinicalgenome.org/r/c72e7f54-370b-4ea9-9248-e1934db681a2"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/17f9afa6-a82a-45fe-9240-03763a3485e2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32896923","rdfs:label":"F5","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/17f9afa6-a82a-45fe-9240-03763a3485e2","type":"Family","rdfs:label":"F5","member":{"id":"https://genegraph.clinicalgenome.org/r/e009b85a-5a8d-423b-b61a-cfbf357b9192","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32896923","rdfs:label":"II-5","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":35,"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"lower back pain","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/28db6e40-75ee-4cec-bed5-7999bc1a41f7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32896923","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8e3bf55-93aa-4086-b9d5-8152c007a050","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.1333G>A (p.Gly445Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7511320"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0003327","obo:HP_0003691","obo:HP_0008994","obo:HP_0003236"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e009b85a-5a8d-423b-b61a-cfbf357b9192"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/667ec199-098d-4b69-bb03-0095a8e867e5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28881388","rdfs:label":"Family 2","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/667ec199-098d-4b69-bb03-0095a8e867e5","type":"Family","rdfs:label":"Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/b5a74502-eb99-4db4-88bc-468b7a7a42e0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28881388","rdfs:label":"2/V:6","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":40,"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"axial myopathy; fiber splitting; rare regenerating fibers; type 1 fiber predominance","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/53cf9284-1f9a-4fd5-a6e3-d049e26d587d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28881388","allele":{"id":"https://genegraph.clinicalgenome.org/r/95c8d89e-dcac-47dc-960f-89d5c1f9f59c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0003701","obo:HP_0003236"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b5a74502-eb99-4db4-88bc-468b7a7a42e0"}},{"id":"https://genegraph.clinicalgenome.org/r/15ae2009-7cb5-48b8-a4b9-b85f459e8a00_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32342993","rdfs:label":"Family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/15ae2009-7cb5-48b8-a4b9-b85f459e8a00","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/26ccf05a-b79a-4376-8c65-8448239888dc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32342993","rdfs:label":"III.5","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":15,"detectionMethod":"Both mendelian exome and whole exome werer performed on the proband, WES on one of the parents.","firstTestingMethod":"Exome sequencing","secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/46f81e04-dff8-4758-98fa-0c50670e4582_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32342993","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8e3bf55-93aa-4086-b9d5-8152c007a050"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/26ccf05a-b79a-4376-8c65-8448239888dc"}},{"id":"https://genegraph.clinicalgenome.org/r/d01a50c2-b573-4831-8c91-504cb41be481_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"T11","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/d01a50c2-b573-4831-8c91-504cb41be481","type":"Family","rdfs:label":"T11","member":{"id":"https://genegraph.clinicalgenome.org/r/411cd69b-9305-4334-bc91-c646e0c3cf2f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"V-1","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/93fc2b58-20e5-4441-ac09-c7e441fa81d9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":true,"phenotypeFreeText":"Calf hypertrophy, onset at 12, still walking at 14.","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/411cd69b-9305-4334-bc91-c646e0c3cf2f"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/dcd28b25-4e9c-4688-b42c-27f8c92957e2_proband_segregation","type":"FamilyCosegregation","dc:description":"Common mutation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"B501","estimatedLodScore":4.03,"family":{"id":"https://genegraph.clinicalgenome.org/r/dcd28b25-4e9c-4688-b42c-27f8c92957e2","type":"Family","rdfs:label":"B501","member":{"id":"https://genegraph.clinicalgenome.org/r/2e6622bd-a829-4d96-a91a-fa7327415bb7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","rdfs:label":"703","detectionMethod":"Markers based haplotyping, heteroduplex based variant screening, and direct sequencing","firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ab8854a9-0d18-4409-b202-6f160f02f40b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7720071","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf2f5322-0416-49fc-bf50-abce83b272b7"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":true,"phenotypeFreeText":"General LGMD, high penetrance,","phenotypeNegativeAlleleNegative":13,"phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/2e6622bd-a829-4d96-a91a-fa7327415bb7"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/03a04719-b24a-4a32-96d6-9478207353e7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32896923","rdfs:label":"F1","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/03a04719-b24a-4a32-96d6-9478207353e7","type":"Family","rdfs:label":"F1","member":{"id":"https://genegraph.clinicalgenome.org/r/28812ffb-af35-4870-944d-f01ab0c4fca6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32896923","rdfs:label":"III-4","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":30,"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Biopsy endomysial inflammatory infiltrate was observed, non-specific and very mild myopathic changes, with variation in myofibre size, a variable degree of atrophy of type 1 myofibres, and increased number of internal nuclei.","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a499bba9-1363-4b7c-a0a9-46b4b4d9235f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32896923","allele":{"id":"https://genegraph.clinicalgenome.org/r/36ef6f90-08cd-44be-ac08-5cfa8df35cb0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.1661A>C (p.Tyr554Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA392000338"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypeFreeText":"finger extensors in a few members, single-digit CK elevation, two asymptomatic with elevated CK at the time of publication.","phenotypePositiveAllelePositive":8,"phenotypes":["obo:HP_0003327","obo:HP_0003236","obo:HP_0003749","obo:HP_0008994","obo:HP_0003691"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/28812ffb-af35-4870-944d-f01ab0c4fca6"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/5bf6f52c-daca-4539-9dab-4ccf85d92196_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27259757","rdfs:label":"Family 3","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/5bf6f52c-daca-4539-9dab-4ccf85d92196","type":"Family","rdfs:label":"Family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/e62940c4-bee8-4fa3-8e12-2c5ac3ac0898","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27259757","rdfs:label":"3/II:1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":48,"detectionMethod":"Full gene sequencing and some haplotyping on several families.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Proximal limb, paraspinal weakness, back pain, ele","phenotypes":["obo:HP_0003236","obo:HP_0003198"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1ced9412-9157-4653-abd9-7743669b3e92_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27259757","allele":{"id":"https://genegraph.clinicalgenome.org/r/95c8d89e-dcac-47dc-960f-89d5c1f9f59c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":false,"phenotypeFreeText":"Proximal limb, paraspinal weakness, back pain, ele","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0003236","obo:HP_0003198"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e62940c4-bee8-4fa3-8e12-2c5ac3ac0898"}},{"id":"https://genegraph.clinicalgenome.org/r/1e28b93d-e2a7-46dd-b7ca-1be906dfed10_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"T18","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/1e28b93d-e2a7-46dd-b7ca-1be906dfed10","type":"Family","rdfs:label":"T18","member":{"id":"https://genegraph.clinicalgenome.org/r/94db9d15-7231-4f6b-bc4b-ec146030d9ed","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"IV-1","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b158e9c4-fdc1-471d-833a-25dbebe58849_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2c16b6-0f22-4c72-8b43-b871007c11b9"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/94db9d15-7231-4f6b-bc4b-ec146030d9ed"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/4bc152b8-598a-4906-9c88-ba0309ce5424_proband_segregation","type":"FamilyCosegregation","dc:description":"Linkage analysis and targeted sequencing","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"IT5414","estimatedLodScore":1.7,"family":{"id":"https://genegraph.clinicalgenome.org/r/4bc152b8-598a-4906-9c88-ba0309ce5424","type":"Family","rdfs:label":"IT5414","member":{"id":"https://genegraph.clinicalgenome.org/r/2024c1d3-b977-47db-86b0-5942dece3041"},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":true,"phenotypeFreeText":"Limb girdle wastinng, Scapulohumeral distribution at the beginning, extensor digitorum brevis muscle hypertrophy","phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0003236","proband":{"id":"https://genegraph.clinicalgenome.org/r/2024c1d3-b977-47db-86b0-5942dece3041"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/09216e87-4169-4b6c-a080-c3b71c1e2507_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27259757","rdfs:label":"Family 1","estimatedLodScore":4.52,"family":{"id":"https://genegraph.clinicalgenome.org/r/09216e87-4169-4b6c-a080-c3b71c1e2507","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/0d8c7832-c495-4534-a25f-71140363032c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27259757","rdfs:label":"II:1","phenotypeFreeText":"Normal creatine kinase levels but with elevated myoglobin.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/574b4fd1-f641-4364-be7f-98c32ab69d2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27259757","allele":{"id":"https://genegraph.clinicalgenome.org/r/95c8d89e-dcac-47dc-960f-89d5c1f9f59c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypeFreeText":"Most patients with significant muscle replacement by fat elevated CK levels. Lost in paraspinal muscles in some patients. Myopathic changes with an increased number of internalized nuclei and variation in fiber size on biopsy. Occasionally, cell necrosis, ring fibres and increased fibrosis. ","phenotypePositiveAllelePositive":15,"phenotypes":["obo:HP_0003701","obo:HP_0003236","obo:HP_0012548","obo:HP_0003198"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0d8c7832-c495-4534-a25f-71140363032c"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/edb9a878-11fa-4916-b9b6-6146a6993bdd_proband_segregation","type":"FamilyCosegregation","dc:description":"only two affected.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"US9344","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/edb9a878-11fa-4916-b9b6-6146a6993bdd","type":"Family","rdfs:label":"US9344","member":{"id":"https://genegraph.clinicalgenome.org/r/49ef0c09-32b9-4462-8c83-b88e8c829a4a"},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":false,"phenotypeFreeText":"Onset at 10-14, loss walking at 28-29 yo.","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/49ef0c09-32b9-4462-8c83-b88e8c829a4a"}},{"id":"https://genegraph.clinicalgenome.org/r/d6a7fa62-e1cc-4e50-bdea-0d024bf0d5df_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"S5393","estimatedLodScore":2.06,"family":{"id":"https://genegraph.clinicalgenome.org/r/d6a7fa62-e1cc-4e50-bdea-0d024bf0d5df","type":"Family","rdfs:label":"S5393","member":{"id":"https://genegraph.clinicalgenome.org/r/d9f0eca2-fd13-4a7d-8d49-7881eba9b872","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","rdfs:label":"IV-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":13,"firstTestingMethod":"Linkage analysis","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8c7ebfd8-3eaa-44a7-a367-fc654a15679b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9150160","allele":{"id":"https://genegraph.clinicalgenome.org/r/c94006f3-c107-44b8-9e17-cc88ec71a91f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.1699G>T (p.Gly567Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA233622"}},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":true,"phenotypeFreeText":"limb-girdle wasting","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0003236","proband":{"id":"https://genegraph.clinicalgenome.org/r/d9f0eca2-fd13-4a7d-8d49-7881eba9b872"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b158e9c4-fdc1-471d-833a-25dbebe58849_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Marked as 0.1 (or 0) due to no pedigree and no clear information for segregation (negative genotype unaffected number unavailable). ","calculatedScore":2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94db9d15-7231-4f6b-bc4b-ec146030d9ed"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/93fc2b58-20e5-4441-ac09-c7e441fa81d9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Marked as 0.1 (or 0) due to no pedigree and no clear information for segregation (negative genotype unaffected number unavailable). ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/411cd69b-9305-4334-bc91-c646e0c3cf2f"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8c7ebfd8-3eaa-44a7-a367-fc654a15679b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"No functional study other than predictions, a different amino acid change reported in AR LGMD. Score 0 or something? ","calculatedScore":1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9f0eca2-fd13-4a7d-8d49-7881eba9b872"}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ab8854a9-0d18-4409-b202-6f160f02f40b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"PMID: 9642272; Fig3, COS7 cell expression showed autolytic defects; Fig.7 & table; considered as a founder mutation. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e6622bd-a829-4d96-a91a-fa7327415bb7"}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/489a4a05-75df-4008-a527-c012ee19d437_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Marked as 0.1 (or 0) due to no pedigree and no clear information for segregation (negative genotype unaffected number unavailable). PMID: 9642272; Fig3, COS7 cell expression showed autolytic defects; Fig.7 & table; considered as a founder mutation. ","calculatedScore":1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26357d11-b566-4224-9fbf-305860bc3b85"}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6f7dbd92-77a0-4fe7-9308-98ce7f4cc383_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46f81e04-dff8-4758-98fa-0c50670e4582_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Lower or default? Fig3. in vitro expression study showing autolytic defect. But family 1 proband with seemingly normal CAPN3 expression on western, caveating inter-lab variability and reliability of western on this protein.. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26ccf05a-b79a-4376-8c65-8448239888dc"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/53cf9284-1f9a-4fd5-a6e3-d049e26d587d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"PMID: 28881388, Fig.2F lowered CAPN3 protein on western; Lower score as gene impact based on muscle western alone.  ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5a74502-eb99-4db4-88bc-468b7a7a42e0"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5e6f415c-19fb-4d44-87b2-62c92a803bf2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"PMID: 28881388, Fig.2F reduced CAPN3 protein; Lower score as gene impact based on muscle western alone. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/059d1dfe-4ecb-432f-bf13-aee6e471023a"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2a1bba15-b25d-4d84-95e0-19161406d078_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Score 0, to keep Interesting variant with function evidencee.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07930a17-7cae-47a2-8ce2-ca7fa76c6315","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10330340","rdfs:label":"French-Ge´ne´thon (R448H)","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"symmetrical and selective atrophy of the pelvic, scapular, and trunk muscles","phenotypes":["obo:HP_0003236","obo:HP_0008946","obo:HP_0009060"],"secondTestingMethod":"Genotyping","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/2a1bba15-b25d-4d84-95e0-19161406d078_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10330340","allele":{"id":"https://genegraph.clinicalgenome.org/r/9204f29c-d47b-48d2-a04a-fd330adf939a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000070.3(CAPN3):c.1343G>A (p.Arg448His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347482"}},"paternityMaternityConfirmed":"none"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/28db6e40-75ee-4cec-bed5-7999bc1a41f7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Reported in several AR screening case studies (PubMed: 10330340; 26301378;  30564623; 30919934), no current functional study, other than in silico production. ","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e009b85a-5a8d-423b-b61a-cfbf357b9192"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4a9678fb-e1b1-42e9-8523-548cafbefc37_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Fig4 western blot demonstrated CAPN3 protein reduction, Lower score as gene impact based on muscle western alone. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/835bd478-7f96-4748-8758-ccb3b1458480"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1ced9412-9157-4653-abd9-7743669b3e92_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Fig2.Calpain 3 expression is reduced to 5–15% of normal for both the 94 kDa and 30 kDa fragments; Lower score as gene impact based on muscle western alone.\n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e62940c4-bee8-4fa3-8e12-2c5ac3ac0898"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a499bba9-1363-4b7c-a0a9-46b4b4d9235f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Fig.4 reduced CAPN3 protein in 3 family members; Lower score as gene impact based on muscle western alone. \n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28812ffb-af35-4870-944d-f01ab0c4fca6"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/574b4fd1-f641-4364-be7f-98c32ab69d2c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Fig2.Calpain 3 expression is reduced to 5–15% of normal for both the 94 kDa and 30 kDa fragments; Lower score as gene impact based on muscle western alone.  ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d8c7832-c495-4534-a25f-71140363032c"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0.7}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.2}],"evidenceStrength":"Definitive","sequence":3505,"specifiedBy":"GeneValidityCriteria8","strengthScore":17.2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/aoAEEsjno3o","type":"GeneValidityProposition","disease":"obo:MONDO_0016971","gene":"hgnc:1480","modeOfInheritance":"obo:HP_0032113"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_6f7dbd92-77a0-4fe7-9308-98ce7f4cc383-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}